Kenneth C. Frazier, executive vice president and president, Global Human Health, Merck & Co., Inc. Annual conference of the

RMID:C328MY

Preview

Image details

Contributor:

WENN Rights Ltd / Alamy Stock Photo

Image ID:

C328MY

File size:

17.2 MB (500.1 KB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

2000 x 3000 px | 16.9 x 25.4 cm | 6.7 x 10 inches | 300dpi

Date taken:

2 October 2008

Photographer:

WENN

More information:

This image could have imperfections as it’s either historical or reportage.

Kenneth C. Frazier, executive vice president and president, Global Human Health, Merck & Co., Inc. Annual conference of the Sandra Day O'Connor Project on the State of the Judiciary at the Georgetown University Law Center Washington DC, USA - 02.10.08

Available for Editorial use only.

Search stock photos by tags

news

Similar stock images

RMRRR4D2–Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. (L), Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca(2nd L), Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. (3rd L) Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson (C), Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. (3rd R), Albert Bourla, DVM, Ph.D. Chief Executive Officer, Pfizer(2nd R) and Olivier Brandicourt, M.D., Chief Executive Officer Sanofi (R) appear

RMRRR3N3–Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. (L), Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca(2nd L), Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. (3rd L) Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson (C), Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. (3rd R), Albert Bourla, DVM, Ph.D. Chief Executive Officer, Pfizer(2nd R) and Olivier Brandicourt, M.D., Chief Executive Officer Sanofi (R) appear

RMRRR65X–February 26, 2019 - Washington, District of Columbia, U.S. - Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. (L), Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca(2nd L), Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. (3rd L) Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson.(C), Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. (3rd R), Albert Bourla, DVM, Ph.D. Chief Executive Officer, Pfizer(2nd R) and Olivier

RMW0KEX0–Left to Right: Richard Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth Frazier, chairman and CEO of Merck & Co. Inc., Albert Bourla, CEO of Pfizer, and Olivier Brandicourt, CEO of Sanofi testify during a Senate Finance Committee hearing on Drug Pricing in America on Capitol Hill in Washington, D.C. on February 26, 2019. Photo by Alex Edelman/UPI

RMHM1HYF–United States President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America in the in the Roosevelt Room of the White House in Washington, DC on Tuesday, January 31, 2017. According to its website PhRMA 'represents the country's leading biopharmaceutical researchers and biotechnology companies.' From left to right: Josh Pitcock, Chief of Staff to the Vice President; Stephen Ubl, President and CEO, PhARMA; Kenneth C. Frazier, Chairman and CEO of Merck & Co; the President; and Robert J. Hugin, Executive Chairman, Celgene Corporation. Credi

RMHM1HWP–Washington DC, USA. 31st January 2017. United States President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America in the in the Roosevelt Room of the White House in Washington, DC on Tuesday, January 31, 2017. According to its website PhRMA 'represents the country's leading biopharmaceutical researchers and biotechnology companies.' From left to right: Josh Pitcock, Chief of Staff to the Vice President; Stephen Ubl, President and CEO, PhARMA; Kenneth C. Frazier, Chairman and CEO of Merck & Co Credit: MediaPunch Inc/Alamy Live News

RMRRR6A0–February 26, 2019 - Washington, District of Columbia, U.S. - Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. (L), Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca(2nd L), Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. (3rd L) Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson.(C), Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. (3rd R), Albert Bourla, DVM, Ph.D. Chief Executive Officer, Pfizer(2nd R) and Olivier

RMC328MX–Kenneth C. Frazier, executive vice president and president, Global Human Health, Merck & Co., Inc. Annual conference of the

RMC328N4–Ambassador C. Boyden Gray and Kenneth C. Frazier, executive vice president and president, Global Human Health, Merck & Co.,

Kenneth C. Frazier, executive vice president and president, Global Human Health, Merck & Co., Inc. Annual conference of the

Image details

Search stock photos by tags

Get great features with your free account

Get inspired for your next project!